NWPA & WNY's Veterinary Industry News and Topics

Simperica Trio Marketing Program

Provided by Patterson and Zoetis - Market Hound will provide an Email Marketing campaign for you FREE!

Latest News Posts

Equipment

Chemo Hood Systems Available

Attached is information on a biocabinet line we will carry for use primarily in chemotherapy treatment.  There are 3’ & 4’ models, depending on the capacity needed, theyre approx. $1k difference, and come in around $10k and under before installation. 

Read More »

Denamarin Advanced Package Update

Please be aware that Nutramax has updated their packaging on Denamarin Advanced Small 120ct (DENAMSM120-ADV) over the past month. Customers will start receiving this new packaging if you haven’t already. The actual product formulation has not changed, just packaging. New

Read More »

New Bravecto 1-Month & Promo

Merck is excited to announce their Bravecto 1-Month product. Below are the new skus.  From Merck – This product is fully approved and customers will be able to start placing orders for the product on 9/1/2020, when the Merck promotion

Read More »

Market Trends – VetWatch.com

I wanted to share this information from VetWatch.  They survey over 6,000 clinics across the USA weekly.  They recently added a section called Veterinarian & Pet Owner Sentiments.  Below is just some of the information I pulled from this section. Online pharmacies

Read More »

Dechra has Osurnia

As Dechra announced on July 27 of this year, they have started supplying OSURNIA® (florfenicol-terbinafine-betamethasone acetate) Otic Gel, following our acquisition of the worldwide rights to the manufacturing, marketing and sales of the product from Elanco Animal Health. Dechra is

Read More »

New Grad Study

I know pretty much everyone is looking to add additional doctors. I was reviewing this week’s Brakke Animal Health News & Notes (if you don’t subscribe, I recommend it, great for industry news) and VIN, VBMA & VIN Foundation did

Read More »

Mirataz Exp Extension

Attached is a letter from Jan Cunningham, Dechra’s Director of Regulatory Affairs, North America, explaining the Mirataz®(mirtazapine transdermal ointment) shelf life extension, from 30 months to 48 months, which was approved by FDA in October 2019. The letter includes information

Read More »